External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center

• Published in: BMC urology Vol. 22; no. 1; pp. 41 - 9
• Main Authors: Li, Kai, Yang, Xiao, Zhuang, Juntao, Cai, Lingkai, Han, Jie, Yu, Hao, Zhou, Zijian, Lv, Jianchen, Feng, Dexiang, Yuan, Baorui, Wu, Qikai, Li, Pengchao, Cao, Qiang, Lu, Qiang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 21.03.2022; BioMed Central; BMC
• Subjects: Aged; Analysis; Bladder cancer; Cancer; Complications; Cystectomy - methods; Female; Humans; Invasiveness; Laparoscopic surgery; Laparoscopy; Logistic Models; Lymph Node Excision; Lymph nodes; Lymphatic system; Male; Margins of Excision; Medical prognosis; Middle Aged; Ostomy; Outcome Assessment, Health Care - methods; Outcome Assessment, Health Care - standards; Patients; Pelvic lymph node dissection; Pentafecta; Radical cystectomy; Regression analysis; Retrospective Studies; Small intestine; Surgery; Urinary Bladder - pathology; Urinary Bladder - surgery; Urinary Bladder Neoplasms - mortality; Urinary Bladder Neoplasms - surgery; Urology; Pentafecta; Bladder cancer; Radical cystectomy; Pelvic lymph node dissection

To investigate whether Pentafecta is suitable for bladder cancer patients receiving laparoscopic radical cystectomy (LRC). From November 2013 to December 2020, muscle invasive Bladder Cancer (MIBC) and non-muscle invasive Bladder Cancer (NMIBC) patients who received LRC and urinary diversion were re...